Journal
CLINICAL LUNG CANCER
Volume 21, Issue 1, Pages E1-E5Publisher
CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2019.07.012
Keywords
Brain metastasis; Checkpoint inhibitor; Immunotherapy; Leptomeningeal carcinomatosis; Nivolumab